Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us Membership Collaborators Partners
OPEN ACCESS

Progress in the study of treatment using Chinese medicine for metabolism-related fatty liver disease in children

  • Xiao-Xuan Lin1,
  • Qiang He2,*,
  • Sheng-Jie You2 and
  • Xiao-Hui Zhang2
Gastroenterology & Hepatology Research   2025;7(1):1

doi: 10.53388/2025001

Published online:

 Author information

Citation: Lin XX, He Q, You SJ, Zhang XH. Progress in the study of treatment using Chinese medicine for metabolism-related fatty liver disease in children. Gastroenterol & Hepatol Res. 2025;7(1):1. doi: 10.53388/2025001.

Abstract

Metabolism-associated fatty liver disease (MAFLD) is a disease of hepatic fat accumulation resulting from metabolic disorders. Currently, MAFLD is the most common cause of chronic liver disease in children and adolescents. No effective or safe drugs for treating children with MAFLD are available. The traditional Chinese medicine used for treating MAFLD in children is characterized by being holistically regulated, multileveled, multi-targeting, and very safe. In this paper, the progress in research involving treatment using traditional Chinese medicine for MAFLD in children is reviewed.

Keywords

metabolism-related steatohepatopathy, traditional Chinese medicine, liver complex disease theory, complex-passing method

About this Article

Cite this article
Lin XX, He Q, You SJ, Zhang XH. Progress in the study of treatment using Chinese medicine for metabolism-related fatty liver disease in children. Gastroenterol & Hepatol Res. 2025;7(1):1. doi: 10.53388/2025001.
Copy Export to RIS Export to EndNote
Article History
Received Revised Accepted Published
March 31, 2025
DOI http://dx.doi.org/10.53388/2025001